Information
-
Trademark
-
79377769
-
International Classifications
-
Filing Date
July 27, 2023
a year ago
-
Transaction Date
February 15, 2025
2 months ago
-
Status Date
January 24, 2025
3 months ago
-
Location Date
January 24, 2025
3 months ago
-
Status Code
654
-
Current Location
TMO LAW OFFICE 112
Employee Name
MILLER, CHARLES
-
Attorney Docket Number
310159.246US
Attorney Name
Kevan L. Morgan
-
Owners
Mark Drawing Code
4
Mark Identification
ACCENTIS
Case File Statements
- GS0051: Diagnostic preparations for medical and veterinary purposes; diagnostic preparations for medical and veterinary purposes, in particular recombinantly or synthetically produced antigens, lysates of microorganisms, preparations for conducting serological tests, biochemical preparations for conducting confirmatory tests; diagnostic preparations for medical and veterinary purposes, in particular immobilised proteins on a carrier, in particular a biochip, microbead, nanobead, microsphere, test strip, blot, microtiter plate or membrane in the field of autoimmune diagnostics, detection of autoimmune diseases, infection diagnostics, detection of infectious diseases and agents, allergy diagnostics, detection of allergies and allergens, antigen detection, molecular genetic diagnostics, detection of neurological diseases, detection of food intolerances, detection of metabolic diseases, detection of endocrine disorders, detection of inflammation and inflammatory agents, or detection of cancers; diagnostic preparations for medical and veterinary purposes, in particular immobilised proteins on a carrier material, in particular a biochip, microbead, nanobead, microsphere, test strip, blot, microtiter plate or membrane in the field of autoimmune diagnostics, detection of autoimmune diseases, infection diagnostics, detection of infectious diseases and agents, allergy diagnostics, detection of allergies and allergens, antigen detection, molecular genetic diagnostics, detection of neurological diseases, detection of food intolerances, detection of metabolic diseases, detection of endocrine disorders, detection of inflammation and inflammatory agents, or detection of cancers; diagnostic preparations for medical and veterinary purposes, in particular immobilised peptides or immobilised polypeptides on a carrier, in particular a biochip, microbead, nanobead, microsphere, test strip, blot, microtiter plate or membrane in the field of autoimmune diagnostics, detection of autoimmune diseases, infection diagnostics, detection of infectious diseases and agents, allergy diagnostics, detection of allergies and allergens, antigen detection, molecular genetic diagnostics, detection of neurological diseases, detection of food intolerances, detection of metabolic diseases, detection of endocrine disorders, detection of inflammation and inflammatory agents, or detection of cancers; diagnostic preparations for medical and veterinary purposes, in particular immobilised peptides or immobilised polypeptides on a carrier material, in particular a biochip, microbead, nanobead, microsphere, test strip, blot, microtiter plate or membrane in the field of autoimmune diagnostics, detection of autoimmune diseases, infection diagnostics, detection of infectious diseases and agents, allergy diagnostics, detection of allergies and allergens, antigen detection, molecular genetic diagnostics, detection of neurological diseases, detection of food intolerances, detection of metabolic diseases, detection of endocrine disorders, detection of inflammation and inflammatory agents, or detection of cancers; immunoserological test kits, comprising reagents that are matched to one another for conducting immunoserological tests for medical and veterinary purposes for use in disease, disorder, medical or veterinary condition testing and genetic testing; test kits for medical and veterinary diagnostic purposes for use in disease, disorder, medical or veterinary condition testing and genetic testing; test kits for medical and veterinary diagnostic purposes, comprising reagents that are matched to one another for conducting diagnostic tests for use in disease, disorder, medical or veterinary condition testing and genetic testing; test kits for medical and veterinary diagnostic purposes, comprising immobilised proteins on a carrier, in particular a microbead or a nanobead for use in disease, disorder, medical or veterinary condition testing and genetic testing; test kits for medical and veterinary diagnostic purposes, comprising immobilised proteins on a carrier material, in particular a microbead or a nanobead for use in disease, disorder, medical or veterinary condition testing and genetic testing; test kits for medical and veterinary diagnostic purposes, comprising immobilised peptides or immobilised polypeptides on a carrier, in particular a microbead or a nanobead for use in disease, disorder, medical or veterinary condition testing and genetic testing; test kits for medical and veterinary diagnostic purposes, comprising immobilised peptides or immobilised polypeptides on a carrier material, in particular a microbead or a nanobead for use in disease, disorder, medical or veterinary condition testing and genetic testing; test kits for medical and veterinary diagnostic purposes, comprising surface modified or surface activated microbeads or nanobeads enabling the coupling of proteins, polypeptides and peptides for use in disease, disorder, medical or veterinary condition testing and genetic testing; reagents for medical and veterinary diagnostic purposes; reagents for medical and veterinary diagnostic purposes, in particular immobilised proteins on a carrier, in particular a biochip, microbead, nanobead, microsphere, test strip, blot, microtiter plate or membrane in the field of autoimmune diagnostics, detection of autoimmune diseases, infection diagnostics, detection of infectious diseases and agents, allergy diagnostics, detection of allergies and allergens, antigen detection, molecular genetic diagnostics, detection of neurological diseases, detection of food intolerances, detection of metabolic diseases, detection of endocrine disorders, detection of inflammation and inflammatory agents, or detection of cancers; reagents for medical and veterinary diagnostic purposes, in particular immobilised proteins on a carrier material, in particular a biochip, microbead, nanobead, microsphere, test strip, blot, microtiter plate or membrane in the field of autoimmune diagnostics, detection of autoimmune diseases, infection diagnostics, detection of infectious diseases and agents, allergy diagnostics, detection of allergies and allergens, antigen detection, molecular genetic diagnostics, detection of neurological diseases, detection of food intolerances, detection of metabolic diseases, detection of endocrine disorders, detection of inflammation and inflammatory agents, or detection of cancers; reagents for medical and veterinary diagnostic purposes, in particular immobilised peptides or immobilised polypeptides on a carrier, in particular a biochip, microbead, nanobead, microsphere, test strip, blot, microtiter plate or membrane in the field of autoimmune diagnostics, detection of autoimmune diseases, infection diagnostics, detection of infectious diseases and agents, allergy diagnostics, detection of allergies and allergens, antigen detection, molecular genetic diagnostics, detection of neurological diseases, detection of food intolerances, detection of metabolic diseases, detection of endocrine disorders, detection of inflammation and inflammatory agents, or detection of cancers; reagents for medical and veterinary diagnostic purposes, in particular immobilised peptides or immobilised polypeptides on a carrier material, in particular a biochip, microbead, nanobead, microsphere, test strip, blot, microtiter plate or membrane in the field of autoimmune diagnostics, detection of autoimmune diseases, infection diagnostics, detection of infectious diseases and agents, allergy diagnostics, detection of allergies and allergens, antigen detection, molecular genetic diagnostics, detection of neurological diseases, detection of food intolerances, detection of metabolic diseases, detection of endocrine disorders, detection of inflammation and inflammatory agents, or detection of cancers; all aforementioned goods being not for or in connection with ophthalmic and ophthalmological pharmaceutical products.
Case File Event Statements
-
10/5/2023 - a year ago
5 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
8/31/2023 - a year ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IB
Type: REPR
-
9/5/2023 - a year ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
9/9/2023 - a year ago
3 - APPLICATION FILING RECEIPT MAILED
Type: MAFR
-
9/19/2023 - a year ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
10/6/2023 - a year ago
6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Type: RFCR
-
11/13/2023 - a year ago
9 - REFUSAL PROCESSED BY IB
Type: RFNT
-
10/21/2023 - a year ago
8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Type: RFCS
-
10/21/2023 - a year ago
7 - REFUSAL PROCESSED BY MPU
Type: RFRR
-
3/18/2024 - a year ago
12 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
3/18/2024 - a year ago
11 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
3/18/2024 - a year ago
10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
4/10/2024 - a year ago
15 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Type: GNS3
-
4/10/2024 - a year ago
13 - SUSPENSION LETTER WRITTEN
Type: CNSL
-
1/24/2025 - 3 months ago
16 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Type: RCSC
-
4/10/2024 - a year ago
14 - LETTER OF SUSPENSION E-MAILED
Type: GNSL
-
1/27/2025 - 3 months ago
18 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Type: OPNS
-
2/15/2025 - 2 months ago
19 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Type: OPNX
-
1/26/2025 - 3 months ago
17 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Type: OPNR